| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 7.782 | 54.791 | 23.039 | 8.642 | 8.058 | 11.079 |
| Total Income - EUR | - | - | - | - | 22.895 | 58.194 | 24.292 | 9.830 | 14.297 | 12.257 |
| Total Expenses - EUR | - | - | - | - | 22.122 | 55.429 | 22.236 | 7.647 | 10.291 | 9.901 |
| Gross Profit/Loss - EUR | - | - | - | - | 773 | 2.765 | 2.056 | 2.183 | 4.006 | 2.356 |
| Net Profit/Loss - EUR | - | - | - | - | 674 | 2.375 | 1.450 | 2.110 | 3.894 | 2.073 |
| Employees | - | - | - | - | 1 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gyneo S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 13.028 | 9.471 | 8.008 | 6.840 | 5.634 | 4.425 |
| Current Assets | - | - | - | - | 12.867 | 13.794 | 4.575 | 7.006 | 11.469 | 13.716 |
| Inventories | - | - | - | - | 5.799 | 13.718 | 3.264 | 1.449 | 0 | 0 |
| Receivables | - | - | - | - | 7.047 | 103 | 0 | 0 | 8.058 | 10.456 |
| Cash | - | - | - | - | 22 | -26 | 1.311 | 5.557 | 3.410 | 3.261 |
| Shareholders Funds | - | - | - | - | 716 | 3.078 | 4.460 | 6.583 | 10.457 | 12.472 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 12.050 | 10.711 | 100 | 402 | 990 | 1.223 |
| Income in Advance | - | - | - | - | 13.129 | 9.477 | 8.024 | 6.860 | 5.655 | 4.446 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gyneo S.r.l.